Applied Therapeutics: Following Issuance of a Complete Response Letter by FDA, Received Warning Letter Limited to at-007-1002 Study
应用治疗学:在FDA发出完整回应信后,收到针对at-007-1002研究的警告信
Applied Therapeutics: Following Issuance of a Complete Response Letter by FDA, Received Warning Letter Limited to at-007-1002 Study
应用治疗学:在FDA发出完整回应信后,收到针对at-007-1002研究的警告信
使用浏览器的分享功能,分享给你的好友吧